Elizabeth V K Ledger

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 15

Top Topics

Staphylococcus Aureus

Cystic Fibrosis

Top Venues

Antimicrobial agents and chemotherapy

This page only lists publications with an associated author ORCID identifier.

Publications

Elizabeth V K Ledger, Andrew M Edwards
Host-induced cell wall remodeling impairs opsonophagocytosis of Staphylococcus aureus by neutrophils. mBio 15 (8) (2024)
Elizabeth V K Ledger, Andrew M Edwards
Host-induced cell wall remodeling impairs opsonophagocytosis of Staphylococcus aureus by neutrophils. mBio 15 (8) (2024)
Elizabeth V K Ledger, Andrew M Edwards
Host-induced cell wall remodeling impairs opsonophagocytosis of Staphylococcus aureus by neutrophils. mBio (2024)
Elizabeth V K Ledger, Andrew M Edwards
Host-induced cell wall remodeling impairs opsonophagocytosis of Staphylococcus aureus by neutrophils. mBio 15 (8) (2024)
Elizabeth V K Ledger, Katie Lau, Edward William Tate, Andrew M Edwards
XerC Is Required for the Repair of Antibiotic- and Immune-Mediated DNA Damage in Staphylococcus aureus. Antimicrobial agents and chemotherapy 67 (3) (2023)
Elizabeth V K Ledger, Katie Lau, Edward William Tate, Andrew M Edwards
XerC Is Required for the Repair of Antibiotic- and Immune-Mediated DNA Damage in Staphylococcus aureus. Antimicrobial agents and chemotherapy 67 (3) (2023)
Elizabeth V K Ledger, Katie Lau, Edward William Tate, Andrew M Edwards
XerC Is Required for the Repair of Antibiotic- and Immune-Mediated DNA Damage in Staphylococcus aureus. Antimicrobial agents and chemotherapy 67 (3) (2023)
Elizabeth V K Ledger, Katie Lau, Edward William Tate, Andrew M Edwards
XerC Is Required for the Repair of Antibiotic- and Immune-Mediated DNA Damage in Staphylococcus aureus. Antimicrobial agents and chemotherapy (2023)
Elizabeth V K Ledger, Andrew M Edwards
Growth Arrest of Staphylococcus aureus Induces Daptomycin Tolerance via Cell Wall Remodelling. mBio 14 (1) (2023)
Elizabeth V K Ledger, Andrew M Edwards
Growth Arrest of Staphylococcus aureus Induces Daptomycin Tolerance via Cell Wall Remodelling. mBio 14 (1) (2023)
Elizabeth V K Ledger, Katie Lau, Edward William Tate, Andrew M Edwards
XerC Is Required for the Repair of Antibiotic- and Immune-Mediated DNA Damage in Staphylococcus aureus. Antimicrobial agents and chemotherapy (2023)
Elizabeth V K Ledger, Andrew M Edwards
Growth Arrest of Staphylococcus aureus Induces Daptomycin Tolerance via Cell Wall Remodelling. mBio 14 (1) (2023)
Elizabeth V K Ledger, Andrew M Edwards
Growth Arrest of Staphylococcus aureus Induces Daptomycin Tolerance via Cell Wall Remodelling. mBio (2023)
Elizabeth V K Ledger, Katie Lau, Edward William Tate, Andrew M Edwards
XerC Is Required for the Repair of Antibiotic- and Immune-Mediated DNA Damage in Staphylococcus aureus. Antimicrobial agents and chemotherapy 67 (3) (2023)
Carmen J E Pee, Vera Pader, Elizabeth V K Ledger, Andrew M Edwards
A FASII Inhibitor Prevents Staphylococcal Evasion of Daptomycin by Inhibiting Phospholipid Decoy Production. Antimicrobial agents and chemotherapy 63 (4) (2019)